ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,902, issued on Sept. 1, was assigned to Cavalry Biosciences Inc. and University of Florida Research Foundation Inc. (Gainsville, Fla.).

"Compositions for targeting muscle cells and uses thereof" was invented by Nathaniel Eames David (San Francisco), Robert N. O'Brien (Burlington, Vt.), Timothy R. Stowe (San Francisco), Patrick B. Ventura (Richmond, Calif.), James W. West (Bend, Ore.) and Elisabeth Barton (Gainesville, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions that are useful for targeting a signaling pathway modulator to a muscle cell. In some instances, such compositions may be useful in treating a muscle...